545 related articles for article (PubMed ID: 19095574)
1. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
Wagoner MJ; Laronga C; Acs G
Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
[TBL] [Abstract][Full Text] [Related]
2. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
3. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
4. [Breast calcifications with percutaneous vacuum-assisted biopsy diagnosis of malignancy or atypical hyerplasia: correlations with surgical findings].
Piubello Q; Montemezzi S; D'Atri C
Pathologica; 2002 Dec; 94(6):299-305. PubMed ID: 12540993
[TBL] [Abstract][Full Text] [Related]
5. Atypical ductal hyperplasia at margin of breast biopsy--is re-excision indicated?
Arora S; Menes TS; Moung C; Nagi C; Bleiweiss I; Jaffer S
Ann Surg Oncol; 2008 Mar; 15(3):843-7. PubMed ID: 17987337
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
[TBL] [Abstract][Full Text] [Related]
7. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.
Renshaw AA; Cartagena N; Schenkman RH; Derhagopian RP; Gould EW
Am J Clin Pathol; 2001 Jul; 116(1):92-6. PubMed ID: 11447758
[TBL] [Abstract][Full Text] [Related]
8. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
Kunju LP; Kleer CG
Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
[TBL] [Abstract][Full Text] [Related]
9. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience.
Killebrew LK; Oneson RH
Breast J; 2006; 12(4):302-8. PubMed ID: 16848839
[TBL] [Abstract][Full Text] [Related]
11. Predicting cancer on excision of atypical ductal hyperplasia.
Doren E; Hulvat M; Norton J; Rajan P; Sarker S; Aranha G; Yao K
Am J Surg; 2008 Mar; 195(3):358-61; discussion 361-2. PubMed ID: 18206849
[TBL] [Abstract][Full Text] [Related]
12. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
[TBL] [Abstract][Full Text] [Related]
13. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
14. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
[TBL] [Abstract][Full Text] [Related]
15. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device.
Sie A; Bryan DC; Gaines V; Killebrew LK; Kim CH; Morrison CC; Poller WR; Romilly AP; Schilling K; Sung JH
Cancer; 2006 Sep; 107(5):945-9. PubMed ID: 16874817
[TBL] [Abstract][Full Text] [Related]
16. Lobular neoplasia on core-needle biopsy--clinical significance.
Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
[TBL] [Abstract][Full Text] [Related]
17. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy.
Winchester DJ; Bernstein JR; Jeske JM; Nicholson MH; Hahn EA; Goldschmidt RA; Watkin WG; Sener SF; Bilimoria MB; Barrera E; Winchester DP
Arch Surg; 2003 Jun; 138(6):619-22; discussion 622-3. PubMed ID: 12799332
[TBL] [Abstract][Full Text] [Related]
18. Progression risk of columnar cell lesions of the breast diagnosed in core needle biopsies.
Verschuur-Maes AH; Witkamp AJ; de Bruin PC; van der Wall E; van Diest PJ
Int J Cancer; 2011 Dec; 129(11):2674-80. PubMed ID: 21225627
[TBL] [Abstract][Full Text] [Related]
19. Underestimation of malignancy of atypical ductal hyperplasia diagnosed on 11-gauge stereotactically guided Mammotome breast biopsy: an Asian breast screen experience.
Teng-Swan Ho J; Tan PH; Hee SW; Su-Lin Wong J
Breast; 2008 Aug; 17(4):401-6. PubMed ID: 18455920
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy.
Chae BJ; Lee A; Song BJ; Jung SS
World J Surg Oncol; 2009 Oct; 7():77. PubMed ID: 19852801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
